Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all

Bluebird Bio's competitors and similar companies include Adaptimmune.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Founding Date
Founding Date
1992
Founding Date
2008
Type
Type
Public
Type
Public
Tags
Locations
Locations
Somerville, US HQ
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Employees
Employees
32338% decrease
Employees
4007% decrease
Valuation ($)
Valuation ($)
95.4 m
Valuation ($)
188.5 m

Financial

Revenue (est.)
Revenue (est.)
$83.8m (FY, 2024)
Revenue (est.)
$178m (FY, 2024)
Cost of goods
Cost of goods
$89.4m (FY, 2024)
Cost of goods
$70k (FY, 2024)
Gross profit
Gross profit
($5.6m) (FY, 2024)
Gross profit
$178m (FY, 2024)
Net income
Net income
($240.7m) (FY, 2024)
Net income
($70.8m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 409m
Total funding raised
$ 107.5m
For sources of this data, please see the company profile

View Company Profiles

Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

View company